Ursolign Capsule
Product Images NDC 81279-130

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ursolign (NDC 81279-130). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pangea Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (5e248968 A19d 4b59 9873 Fba89f6b7fb1 01)

Chemical structure of ursodiol, the active ingredient in URSOLIGN 150 mg capsules by Pangea Pharmaceuticals. The diagram depicts the molecule's ring structure with hydroxyl and carboxyl functional groups.*

FDA Label Image

Image (5e248968 A19d 4b59 9873 Fba89f6b7fb1 02)

Label for URSOLIGN ursodiol capsules 150 mg by Pangea Pharmaceuticals, LLC. The label shows the NDC 81279-130-60 with 60 capsules per package. It includes usage instructions, storage conditions (20 to 25°C), and a child-resistant packaging notice. A barcode and space for batch details are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.